Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin for OAB symptoms after PVP for BPH
NCT00826527Phase 4Unknown
- Sponsor
- Seattle Urology Research Center
- Start
- Jan 2007
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB), sponsored by Seattle Urology Research Center. Status: unknown.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00826527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00826527.